New receptor agonist combinations, a once-monthly GLP-1, and full retatrutide data are all on the agenda, along with a huge spectrum of other diabetes-related content.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/latest-glp-1-based-therapy-be-featured-ada-2026a1000i3q?src=rss
Author :
Publish date : 2026-06-01 08:29:00
Copyright for syndicated content belongs to the linked Source.